Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 5, 2024 FORM 4 SUBMISSION
4 Feb 5, 2024 FORM 4 SUBMISSION
4/A Jan 3, 2024 FORM 4/A SUBMISSION
SC 13G Dec 22, 2023 SCHEDULE 13G
4 Dec 21, 2023 FORM 4 SUBMISSION
3/A Dec 20, 2023 FORM 3/A SUBMISSION
8-K Dec 20, 2023 CURRENT REPORT
4 Dec 19, 2023 FORM 4 SUBMISSION
4 Dec 19, 2023 FORM 4 SUBMISSION
4 Dec 4, 2023 FORM 4 SUBMISSION
8-K Nov 14, 2023 CURRENT REPORT
10-Q Nov 14, 2023 10-Q
8-K Oct 4, 2023 CURRENT REPORT
8-K Aug 23, 2023 CURRENT REPORT
8-K Aug 14, 2023 CURRENT REPORT
10-Q Aug 14, 2023 10-Q
4 Jun 2, 2023 FORM 4 SUBMISSION
8-K May 15, 2023 CURRENT REPORT
10-Q May 15, 2023 10-Q
8-K Mar 31, 2023 CURRENT REPORT
10-K Mar 31, 2023 10-K
8-K Mar 7, 2023 CURRENT REPORT
SC 13D/A Feb 21, 2023 AMENDMENT NO. 6 TO SCHEDULE 13D
D Jan 31, 2023
4 Jan 20, 2023 FORM 4 SUBMISSION
← Newer Page 3 of 50 · 1238 filings Older →